If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Ligands Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Cell Death Medicine & Life Sciences
CD274 Antigen Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 703 Citations
  • 14 h-Index
  • 101 Article
  • 5 Review article
  • 1 Letter

A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma

Matsubara, T., Takada, K., Azuma, K., Takamori, S., Toyokawa, G., Haro, A., Osoegawa, A., Tagawa, T., Kawahara, A., Akiba, J., Okamoto, I., Nakanishi, Y., Oda, Y., Hoshino, T. & Maehara, Y., Jun 15 2019, In : Annals of Surgical Oncology. 26, 6, p. 1925-1933 9 p.

Research output: Contribution to journalArticle

Squamous Cell Carcinoma
Ligands
Lung
CD274 Antigen
Immunotherapy

A Positive Correlation Between the EZH2 and PD-L1 Expression in Resected Lung Adenocarcinomas

Toyokawa, G., Takada, K., Tagawa, T., Hamamoto, R., Yamada, Y., Shimokawa, M., Oda, Y. & Maehara, Y., Feb 1 2019, In : Annals of Thoracic Surgery. 107, 2, p. 393-400 8 p.

Research output: Contribution to journalArticle

Ligands
Adenocarcinoma of lung
Enhancer of Zeste Homolog 2 Protein
Recurrence
Lymphatic Vessels

Association of Low Body Mass Index with Poor Clinical Outcomes after Resection of Non-small Cell Lung Cancer

Takada, K., Shimokawa, M., Akamine, T., Ono, Y., Haro, A., Osoegawa, A., Tagawa, T. & Mori, M., Apr 1 2019, In : Anticancer research. 39, 4, p. 1987-1996 10 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Body Mass Index
Disease-Free Survival
Survival
CD274 Antigen
1 Citation (Scopus)

Co-expression of IDO1 and PD-L1 in lung squamous cell carcinoma: Potential targets of novel combination therapy

Takada, K., Kouhashi, K., Shimokawa, M., Haro, A., Osoegawa, A., Tagawa, T., Seto, T., Oda, Y. & Maehara, Y., Feb 1 2019, In : Lung Cancer. 128, p. 26-32 7 p.

Research output: Contribution to journalArticle

CD274 Antigen
Indoleamine-Pyrrole 2,3,-Dioxygenase
Squamous Cell Carcinoma
Lung
Therapeutics

HMGB1 blockade significantly improves luminal fibrous obliteration in a murine model of bronchiolitis obliterans syndrome

Takamori, S., Shoji, F., Okamoto, T., Kozuma, Y., Matsubara, T., Haratake, N., Akamine, T., Katsura, M., Takada, K., Toyokawa, G., Tagawa, T. & Maehara, Y., Apr 1 2019, In : Transplant Immunology. 53, p. 13-20 8 p.

Research output: Contribution to journalArticle

Bronchiolitis Obliterans
Interleukin-10
Interferons
Allografts
Isografts